FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, Reuters reports
October 01, 2020 at 07:39 AM EDT
Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer's “unexplained illness.”
